United Kingdom - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, United Kingdom Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry decreased by 1.1% year on year. In 2019, the country was ranked number 14 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $542,693,029.31 Million PPP. United Kingdom is overtaken by Taiwan, which was number 13 at $581,419,961.53 Million PPP and is followed by Austria at $427,223,717.42 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, an increase of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 542,693,029.31 |
| 2018 | 548,300,741.74 |
| 2017 | 554,022,897.29 |
| 2016 | 555,997,424.35 |
| 2015 | 560,397,811.50 |
How does United Kingdom rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 13 |
#13
Taiwan
|
581,419,961.53 | 2019 | +7.2 % | +3.5 % | View data | |
| 14 |
#14
United Kingdom
|
542,693,029.31 | 2019 | -1.0 % | -1.1 % | View data | |
| 15 |
#15
Austria
|
427,223,717.42 | 2019 | +3.0 % | +2.4 % | View data | |